Search research articles
Contact Us
Filters
Showing results (321-330 of 410) with videos related to
Page
of 41
Sort By:
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
September 3, 2013
Objectives and design of the hemodialysis fistula maturation study
Laura M Dember, Peter B Imrey, Gerald J Beck, et al.
Journal of the American Society of Nephrology : JASN
|
July 16, 2017
Intimal Hyperplasia, Stenosis, and Arteriovenous Fistula Maturation Failure in the Hemodialysis Fistula Maturation Study
Alfred K Cheung, Peter B Imrey, Charles E Alpers, et al.
Journal of the American Society of Nephrology : JASN
|
June 24, 2003
The rationale and design of the AASK cohort study
Lawrence J Appel, John Middleton, Edgar R Miller, et al.
JAMA Network Open
|
October 13, 2025
Liraglutide vs Semaglutide vs Dulaglutide in Veterans With Type 2 Diabetes
Catherine G Derington, Amara Sarwal, Guo Wei, et al.
Contemporary Clinical Trials
|
November 28, 2024
The Sit Less, Interact and Move More (SLIMM-2) Trial: Protocol for a randomized control trial of a sedentary behavior intervention, resistance training and semaglutide on sedentary behavior in persons with chronic kidney disease
Jesse C Christensen, Shuchi Anand, Glenn M Chertow, et al.
The New England Journal of Medicine
|
September 24, 2020
Dapagliflozin in Patients with Chronic Kidney Disease
Hiddo J L Heerspink, Bergur V Stefánsson, Ricardo Correa-Rotter, et al.
Kidney International
|
September 24, 2021
A pre-specified analysis of the Dapagliflozin and Prevention of Adverse Outcomes in Chronic Kidney Disease (DAPA-CKD) randomized controlled trial on the incidence of abrupt declines in kidney function
Hiddo J L Heerspink, David Cherney, Douwe Postmus, et al.
JAMA
|
November 21, 2002
Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial
Jackson T Wright, George Bakris, Tom Greene, et al.
Journal of the American Society of Nephrology : JASN
|
July 12, 2019
Performance of GFR Slope as a Surrogate End Point for Kidney Disease Progression in Clinical Trials: A Statistical Simulation
Tom Greene, Jian Ying, Edward F Vonesh, et al.
Circulation. Cardiovascular Imaging
|
February 25, 2012
Determinants of left ventricular mass in patients on hemodialysis: Frequent Hemodialysis Network (FHN) Trials
Christopher T Chan, Tom Greene, Glenn M Chertow, et al.
Page
of 41
Search research articles
Search
Showing results (321-330 of 410) with videos related to
Sort By:
Page
of 41
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
September 3, 2013
Objectives and design of the hemodialysis fistula maturation study
Laura M Dember, Peter B Imrey, Gerald J Beck, et al.
Journal of the American Society of Nephrology : JASN
|
July 16, 2017
Intimal Hyperplasia, Stenosis, and Arteriovenous Fistula Maturation Failure in the Hemodialysis Fistula Maturation Study
Alfred K Cheung, Peter B Imrey, Charles E Alpers, et al.
Journal of the American Society of Nephrology : JASN
|
June 24, 2003
The rationale and design of the AASK cohort study
Lawrence J Appel, John Middleton, Edgar R Miller, et al.
JAMA Network Open
|
October 13, 2025
Liraglutide vs Semaglutide vs Dulaglutide in Veterans With Type 2 Diabetes
Catherine G Derington, Amara Sarwal, Guo Wei, et al.
Contemporary Clinical Trials
|
November 28, 2024
The Sit Less, Interact and Move More (SLIMM-2) Trial: Protocol for a randomized control trial of a sedentary behavior intervention, resistance training and semaglutide on sedentary behavior in persons with chronic kidney disease
Jesse C Christensen, Shuchi Anand, Glenn M Chertow, et al.
The New England Journal of Medicine
|
September 24, 2020
Dapagliflozin in Patients with Chronic Kidney Disease
Hiddo J L Heerspink, Bergur V Stefánsson, Ricardo Correa-Rotter, et al.
Kidney International
|
September 24, 2021
A pre-specified analysis of the Dapagliflozin and Prevention of Adverse Outcomes in Chronic Kidney Disease (DAPA-CKD) randomized controlled trial on the incidence of abrupt declines in kidney function
Hiddo J L Heerspink, David Cherney, Douwe Postmus, et al.
JAMA
|
November 21, 2002
Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial
Jackson T Wright, George Bakris, Tom Greene, et al.
Journal of the American Society of Nephrology : JASN
|
July 12, 2019
Performance of GFR Slope as a Surrogate End Point for Kidney Disease Progression in Clinical Trials: A Statistical Simulation
Tom Greene, Jian Ying, Edward F Vonesh, et al.
Circulation. Cardiovascular Imaging
|
February 25, 2012
Determinants of left ventricular mass in patients on hemodialysis: Frequent Hemodialysis Network (FHN) Trials
Christopher T Chan, Tom Greene, Glenn M Chertow, et al.
Page
of 41